How Oncotarget is contributing to Cancer Research

Oncotarget is a weekly medical journal that focuses on oncology and treatment protocols that are used to help improve the handling of cancer patients. The journal mainly focuses on the research that seeks to identify the root course of cancer and its treatment. Oncotarget was created in 2010 and has managed to attract some high-level researchers.

Ever since its creation, the journal has received positive reviews on the work posted. Recent statistical data shows an increase in value from different indicators. During the five years, the journal has received an impact factor of 2.235.

The journal is indexed in; PubMed, SciSearch®, Biological Abstract, DOAJ (Directory of Open Access Journals), Journal Citation Reports and The Open Access Initiative among others. It is also a member of COPE (Committee on Publication Ethics). The journal also follows the principles of COPE. Read more about Oncotarget at Bioxbio.

Mikhail Blagosklonny together with Andrei V. Gudkov serves as the editors-in-chief. The duo also works in Roswell Park Cancer Institute based in Buffalo, New York. The Institute had spearheaded cancer research and treatment since 1894 when Dr. Roswell Park founded it.

Oncotarget has also attracted renowned researchers from different cancer research institutes who serve in the Founding Editorial Board. These editors help to evaluate the manuscript submitted to the journal following their scientific credit and level.

Other than oncology, the journal also tries to accept research publications from other medical fields, such as Chromosome, Immunology, and Microbiology, etc. The standard publication fee for a complete research paper is $3,400.

Oncotarget credits its rise in popularity to punctual, constructive, insightful, and complete dedication by authors in their publications. It also conducts interviews with most of its notable authors and publishes the interview on their platform. Each of the papers can be printed, in a case of a special demand.

The journal also enables extraordinary medical discoveries to be shared and accessed quickly, by making the information readily and widely available. Through this journal, researchers are now able to contribute to the expansion of science.

Four members of Oncotarget have won Breakthrough Prize, which is the highest prize in the medical field. Oncotarget is also available on Dove Press.